In recent years, the company has successively developed new products like oligo molecular weight sodium hyaluronate, very high molecular weight sodium hyaluronate, HA plus, Treme HA. In 2018, the company established a strategic plan of ‘transforming and upgrading to the downstream medical and industrial chain while steadily increasing the market share of sodium hyaluronate.’ The R&D center will continue to innovate according to the plan.